Drug Lobby Touts Pfizer's Kickback Challenge At High Court
The pharmaceutical industry's largest lobbying group Monday threw its weight behind Pfizer's attack on federal health-fraud enforcers, warning the U.S. Supreme Court that capacious views of a key kickback law have...To view the full article, register now.
Already a subscriber? Click here to view full article